Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-07

Clinical Trial Update: Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of mometasone furoate dry powder inhaler, fluticasone propionate, and montelukast on bone mineral density in asthm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone propionate (Fluticasone propionate)
  • Mometasone furoate dry powder inhaler (mometasone furoate)
  • Montelukast (Montelukast)

Snippet

Sponsor: Organon and Co | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2011-03-07